| Authors: |
Adesoye T; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dumbrava EE; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Raghav KPS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sahin AA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chen H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Javle MM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pant S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alhalabi O; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Le X; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Valero V; Division of Cancer Medicine, Department of Breast Medical Oncology, The University of MD Anderson Cancer Center, Houston, Texas., Pohlmann PR; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Cancer Medicine, Department of Breast Medical Oncology, The University of MD Anderson Cancer Center, Houston, Texas., Meric-Bernstam F; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
